EORTC at ESMO 2017 in Madrid
1 Sep 2017
EORTC, in collaboration with ESMO and EACR, will present a session on tumours with rare oncogenic lesions: From pre-clinical to clinical validation on 10 September from 11:00 to 12:30.
Professor Françoise Meunier, Director of Special Projects at EORTC, will co-chair the Hans Keulen Memorial debate on Lost in rehabilitation on 11 September from 13:00 to 14:30; and Ms Anastassia Negrouk, Head of International Policy Office, will be a speaker at the Challenge Your Expert (CYE) session on the new EU clinical trials and data protection regulations. This session will take place on 11 September at 08:00.
EORTC will also be presenting three oral abstract session and five abstracts in poster sessions at ESMO (September 8-12, 2017) in Madrid.
Oral presentations
- Time to definitive failure to the first tyrosine kinase inhibitor in localized gastrointestinal stromal tumors (GIST) treated with imatinib as an adjuvant: final results of the EORTC STBSG, AGITG, UNICANCER, FSG, ISG, and GEIS randomized trial (Abstract LBA55)
Session: Sarcoma
Time: Saturday September 9, 11:00 to 12:30
Location: Granada Auditorium
Speaker: P.G. Casali
- Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME) (Abstract LBA35)
Session: Genitourinary tumours, non-prostate
Time: Saturday September 9, 9:15 to 10:45
Location: Madrid Auditorium
Speaker: A. Bex
- Not all small node negative (pT1abN0) breast cancers are similar: Outcome results from the EORTC 10041/BIG 3-04 (MINDACT) trial (Abstract 150O)
Session: Breast cancer, early stage
Time: Friday September 8, 14:00 to 15:30
Location: Pamplona Auditorium
Speaker: K. Tryfonidis
Poster sessions
- EORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective clinical trials: clinical profile and response to systemic therapy (Abstract 1496P)
Session: Poster Display session
Time: Monday September 11, 13:15 to 14:15
Location: Hall 8
Authors: Touati N, Schöffski P, Litière S, Judson I, Sleijfer S, van der Graaf WT, Italiano A, Isambert N, Gil T, Blay JY, Stark D, Brodowicz T, Marréaud S, Gronchi A
- Evolution in Neutrophil-to-lymphocyte ratio (NLR) among advanced Soft Tissue Sarcoma (STS) patients treated with pazopanib within EORTC 62043/62072 trials (Abstract 1502P)
Session: Poster Display session
Time: Monday September 11, 13:15 to 14:15
Location: Hall 8
Authors: De Maio E, Touati N, Litière S, Sleijfer S, van der Graaf WT, Le Cesne A, D’Ambrosio L, Casali PG, Italiano A, Desar I, Gronchi A
- Hope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (Abstract 1106TIP)
Session: Poster Display session
Time: Sunday September 10, 13:15 to 14:15
Location: Hall 8
Authors: L.Locati, C.Caballero, C. Fortpied, F. Perrone, S. Pilotti, K.J. Harrington, V. Gregoire, L. Licitra
- Diagnostic and therapeutic strategies for elderly patients with advanced Non-Small cell lung cancer (NSCLC): results from an EORTC pan-european survey (Abstract 1371P)
Session: Poster Display session
Time: Saturday September 9, 13:15 to 14:15
Location: Hall 8
Authors: M. Giaj Levra, J. Menis, A. Luciani, E. De Maio, B. Hasan, T. Berghmans, M.A. Messiani, M. De Waele, A.-M. Dingemans, J. Donckele, C. Faivre-Finn, N. Girard, L. Greillier, S. Lantuéjoul, M. O’Brien, M. Reck, K. Tryfonidis, H. Wildiers, B. Besse, S. Novello
- Diversity of brain metastasis (BM) management in non-small cell lung cancer (NSCLC) in Europe (EU): Results of the Young Investigators European Organisation for Research and Treatment of Cancer Lung Cancer Group (YI EORTC LCG) survey (Abstract 1372P)
Session: Poster Display session
Time: Saturday September 9, 13:15 to 14:15
Location: Hall 8
Authors: Antonin Levy, Corinne Faivre-Finn, Baktiar Hasan, Eleonora De Maio, Anna S. Berghof, Anne-Marie Dingemans, Silvia Novello, Thierry Berghmans, Benjamin Besse, Lizza Hendriks
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023